Woodline Partners LP Seres Therapeutics, Inc. Transaction History

Woodline Partners LP

  • $9.97 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.75 - $1.56 $566,696 - $1.18 Million
755,595 Added 58.56%
2,045,871 $1.58 Million
Q4 2023

Feb 14, 2024
BUY
$0.93 - $2.15 $1.01 Million - $2.34 Million
1,090,276 Added 545.14%
1,290,276 $1.81 Million
Q3 2023

Nov 14, 2023
SELL
$2.33 - $5.07 $101,576 - $221,026
-43,595 Reduced 17.9%
200,000 $476,000
Q2 2023

Aug 14, 2023
BUY
$4.67 - $6.55 $1.14 Million - $1.6 Million
243,595 New
243,595 $1.17 Million

Others Institutions Holding MCRB

# of Institutions
93
Shares Held
46.7M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $102M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email